CA Patent

CA2682162C — Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof

Assigned to Evotec OAI AG · Expires 2016-05-10 · 10y expired

What this patent protects

Fused heterocyclic compounds are provided according to formula 1a or 1b: where R1, R2, and R3 are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, incl…

USPTO Abstract

Fused heterocyclic compounds are provided according to formula 1a or 1b: where R1, R2, and R3 are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.

Drugs covered by this patent

Patent Metadata

Patent number
CA2682162C
Jurisdiction
CA
Classification
—
Expires
2016-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Evotec OAI AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.